MX2011009263A - Compuesto para tratamiento de tuberculosis. - Google Patents

Compuesto para tratamiento de tuberculosis.

Info

Publication number
MX2011009263A
MX2011009263A MX2011009263A MX2011009263A MX2011009263A MX 2011009263 A MX2011009263 A MX 2011009263A MX 2011009263 A MX2011009263 A MX 2011009263A MX 2011009263 A MX2011009263 A MX 2011009263A MX 2011009263 A MX2011009263 A MX 2011009263A
Authority
MX
Mexico
Prior art keywords
treatment
tuberculosis
compound
dihydroxypropanoyl
pyridi
Prior art date
Application number
MX2011009263A
Other languages
English (en)
Inventor
Das Kaveri
David Alan Melnick
Shandil Radha
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MX2011009263A publication Critical patent/MX2011009263A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • A61K31/06Phenols the aromatic ring being substituted by nitro groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

(5R)-3-[4-[1-[(2S)-2,3-dihidroxipropanoil]-3,6-dihidro-2H-piridin -4-il]-3,5-difluorofenill-5-(isoxazol-3-iloximetil)oxazolidin-2-o na, o una de sus sales farmacéuticamente aceptables, o uno de sus ésteres hidrolizables in vivo, para usar en el tratamiento de Mycohacterium tuberculosis.
MX2011009263A 2009-03-16 2010-03-16 Compuesto para tratamiento de tuberculosis. MX2011009263A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16038509P 2009-03-16 2009-03-16
PCT/GB2010/050445 WO2010106355A1 (en) 2009-03-16 2010-03-16 Compound for the treatment of tuberculosis

Publications (1)

Publication Number Publication Date
MX2011009263A true MX2011009263A (es) 2011-09-15

Family

ID=42262301

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009263A MX2011009263A (es) 2009-03-16 2010-03-16 Compuesto para tratamiento de tuberculosis.

Country Status (17)

Country Link
US (1) US20120035219A1 (es)
EP (1) EP2408452A1 (es)
JP (1) JP2012520864A (es)
KR (1) KR20110127219A (es)
CN (1) CN102355901A (es)
AR (1) AR075861A1 (es)
AU (1) AU2010224619A1 (es)
BR (1) BRPI1009510A2 (es)
CA (1) CA2755209A1 (es)
EA (1) EA201101328A1 (es)
IL (1) IL214715A0 (es)
MX (1) MX2011009263A (es)
SG (1) SG173770A1 (es)
TW (1) TW201036609A (es)
UY (1) UY32493A (es)
WO (1) WO2010106355A1 (es)
ZA (1) ZA201107562B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200003595T2 (tr) * 1998-06-05 2001-07-23 Astrazeneca Ab Kimyasal bileşikler
CA2476545A1 (en) * 2002-03-29 2003-10-16 Pharmacia & Upjohn Company Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
AU2003265241A1 (en) * 2002-05-23 2003-12-12 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
MX2008007809A (es) * 2005-12-15 2008-09-15 Activbiotics Pharma Llc Usos de rifamicinas.

Also Published As

Publication number Publication date
SG173770A1 (en) 2011-09-29
TW201036609A (en) 2010-10-16
UY32493A (es) 2010-10-29
CA2755209A1 (en) 2010-09-23
JP2012520864A (ja) 2012-09-10
AU2010224619A1 (en) 2011-09-08
BRPI1009510A2 (pt) 2016-03-15
EA201101328A1 (ru) 2012-04-30
US20120035219A1 (en) 2012-02-09
CN102355901A (zh) 2012-02-15
IL214715A0 (en) 2011-11-30
KR20110127219A (ko) 2011-11-24
AR075861A1 (es) 2011-05-04
ZA201107562B (en) 2013-03-27
WO2010106355A1 (en) 2010-09-23
EP2408452A1 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
AU2018260844A1 (en) Processes of making and crystalline forms of a MDM2 inhibitor
CL2009001044A1 (es) Compuestos cristalinos derivados de heterociclos puenteados por un alqueno; utiles en el tratamiento de enfermedades metabolicas, enfermedades circulatorias, enfermedades del snc, entre otras enfermedades.
MY162829A (en) Phthalazinone derivative
CL2009001452S1 (es) Pieza agarre cabezal de cuchillas.
CR20110432A (es) Pirimidinas fusionadas
PH12015500119B1 (en) Composition for controlling plant disease and application therefor
UY34202A (es) Compuestos fungicidas 2-(2-clor0-4-(4-cloro-fenoxi)-fenil]-1-(1,2,4]triazol-1-1l-etanol alquilo sustituidos
EA201071032A1 (ru) Гетероциклическое соединение
ITRM20110140A1 (it) Dispositivo di controllo per macchina utensile.
ATE557023T1 (de) Piperidinylverbindungen als gpcr-agonisten
MX2021006091A (es) Sales y formas solidas de (s)-3-(4-((4-(morfolinometil)bencil)oxi) -1-oxoisoindolin-2-il)piperidin-2,6-diona y composiciones que comprenden y metodos para utilizar las mismas.
MA31985B1 (fr) (r)-2-(4-cyclopropanesulfonyl-phényl)-n-pyrazin-2-yl-3-(tétrahydropyran-4-yl)- propionamide cristallin
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
IT1392648B1 (it) Dispositivo di attacco rapido, particolarmente per macchine operatrici
GEP20156397B (en) Process for the preparation of a rivaroxaban and intermediates formed in said process
ITBO20080138A1 (it) Macchina sezionatrice per il taglio di pannelli.
IT1395257B1 (it) Dispositivo per segare.
MX2011009263A (es) Compuesto para tratamiento de tuberculosis.
MX2021012421A (es) Procesos para preparar derivados de pirrolidina alfa-carboxamida.
TR201911271T4 (tr) Bi̇r baski yataği ci̇hazi
WO2012173504A3 (en) Method for synthesis of the substituted azetidinones and intermediates for their synthesis
FI20096228A (fi) Pituusleikkurin muutonvaihtolaite.
IT1400429B1 (it) Utensile per diaframmi sottili.
HK1122431A1 (en) Method and apparatus for remaining conversation information and database synchronization
ITVI20080035A1 (it) Gruppo morsa-allineatore, particolarmente per saldatrici per polifusione di testa.